Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Net Cash Flow (2017 - 2026)

enVVeno Medical has reported Net Cash Flow over the past 4 years, most recently at $3.7 million for Q4 2020.

  • For Q4 2020, Net Cash Flow rose 326.48% year-over-year to $3.7 million; the TTM value through Dec 2020 reached $7.2 million, up 1257.81%, while the annual FY2025 figure was $1.3 million, 170.26% up from the prior year.
  • Net Cash Flow for Q4 2020 was $3.7 million at enVVeno Medical, up from $3.3 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $5.6 million in Q2 2018 and troughed at -$1.7 million in Q3 2018.
  • A 4-year average of $666213.4 and a median of $263504.0 in 2017 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: plummeted 690.27% in 2018 and later skyrocketed 326.48% in 2020.
  • Year by year, Net Cash Flow stood at -$233795.0 in 2017, then crashed by 519.69% to -$1.4 million in 2018, then dropped by 12.93% to -$1.6 million in 2019, then skyrocketed by 326.48% to $3.7 million in 2020.
  • Business Quant data shows Net Cash Flow for NVNO at $3.7 million in Q4 2020, $3.3 million in Q3 2020, and $843795.0 in Q2 2020.